Specify a stock or a cryptocurrency in the search bar to get a summary
Microport Cardioflow Medtech Corp
2160MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, Angelguide tip-preshaped super sti¬ff guidewire, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company also provides technical consultation and technical services for medical devices clinical trial. MicroPort CardioFlow Medtech Corporation was founded in 2010 and is headquartered in Shanghai, China. Address: No. 1661 Zhangdong Road, Shanghai, China, 201203
Analytics
WallStreet Target Price
19.02 HKDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 2160
Dividend Analytics 2160
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2160
Stock Valuation 2160
Financials 2160
Results | 2019 | Dynamics |